で公開中です！詳しく見る

Baird Medical Investment Holdings

BDMD

時価総額 $1818万

0.5660 USD

-0.0340

5.67%

終値時点更新済み 10月16日 16:00 EDT

1日

-5.67%

5日間

-23.51%

1か月

-46.6%

3か月

-46.1%

6か月

-67.47%

年初来

-57.76%

1年

-63.48%

5年間

-90.57%

10年間

-90.57%

概要： Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.

従業員数： 146

ヘルスケア医療機器

ニュース

ポジティブ

ニュートラル

ネガティブ

センチメント 3か月間

ポジティブ 0%

ニュートラル 100%

ネガティブ 0%

ニュートラル

Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026

NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (“Baird Medical” or the “Company”) (NASDAQ: BDMD), a medical device company focused on the development and commercialization of minimally invasive treatment technologies, today highlighted key business and operational developments from the third quarter of 2026, including expansion into new international markets, continued physician training initiatives and the addition of irreversible electroporation (IRE) technology to its broader technology portfolio through a strategic partnership.

Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026

ニュートラル

Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (“Baird Medical” or the “Company”) (Nasdaq: BDMD), a global medical technology company focused on the development and commercialization of minimally invasive treatment solutions, today announced that management will present at the H.C.

Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference

ニュートラル

Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology

Company Engaged with Interventional Radiology Community at Leading Global Congress in Copenhagen Company Engaged with Interventional Radiology Community at Leading Global Congress in Copenhagen

Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology

ニュートラル

Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026

Revenue increase driven by significant growth in the United States and other strategic markets Revenue increase driven by significant growth in the United States and other strategic markets

Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026

ニュートラル

Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan

NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), announced that the BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle have received product registrations from the Drug Regulatory Authority of Pakistan (“DRAP”), further supporting the Company's commercial activities in the country.

Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan

ニュートラル

Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally

NEW YORK, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”) and Tianjin Yuanshan Medical Technology Co., Ltd., operating under the Alpmed brand (“Alpmed”), a China-based innovator in irreversible electroporation (“IRE”) technology, announced the signing of a strategic cooperation agreement to establish a long-term partnership focused on global development and commercialization of next-generation IRE technologies.

Baird Medical and Alpmed Enter Strategic Partnership to Advance Irreversible Electroporation (IRE) Technology Globally

ニュートラル

Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina

First procedures in two new markets highlight growing global adoption of Baird Medical's minimally invasive microwave ablation technology NEW YORK, June 29, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of the first procedures using its MWA technology in Vietnam and Argentina.

Baird Medical Announces First Microwave Ablation Procedures Using Its Technology in Vietnam and Argentina

ニュートラル

Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion

Enhanced U.S. Presence Centralizes Operations as Company Executes Global Growth Strategy NEW YORK, June 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA ) technology, today announced the relocation of its global headquarters to the U.S., with the establishment of a new corporate office in New York, NY.

Baird Medical Establishes Global Headquarters in New York City, Reinforcing Commitment to U.S. Commercial Expansion

ニュートラル

Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update

Full year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland China Advancing global expansion with appointment of seasoned commercial leader, Mark Saxton, as CEO of Baird Medical U.S. to lead commercial ramp in the United States NEW YORK, April 29, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its financial results for the full year ended December 31, 2025 and provided an update on key strategic and operational initiatives.

Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update

ニュートラル

Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia

NEW YORK, March 16, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful execution of two clinical training workshops in Indonesia.

Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia

ニュースランキングを見る

価格チャートは Lightweight Charts™ を使用して実装されています